does medicaid cover glp-1 drugs for weight loss Coverage of and Spending on GLP-1s McKee's proposed FY2027 budget drops
Description
Cardiovascular health Regular blood pressure and heart rate checks
doi: 10.1016/j.jep.2004.12.010 240 AderibigbeAOEmudianugheTSLawalBS
The result = gradual weight loss
Viking Therapeutics Today VKTX Viking Therapeutics $37.08 +0.71 (+1.95%) As of 07/17/2026 04:00 PM Eastern 52-Week Range $22.96 $43.15 Price Target $93.60 Viking is developing VK2735 in both oral and injectable forms and should begin Phase 3 trials for the oral form in the coming months
Always consult with a qualified healthcare provider before starting any weight loss medication
